Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma

Oral Oncol. 2022 Apr:127:105807. doi: 10.1016/j.oraloncology.2022.105807. Epub 2022 Mar 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albumins
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Carboplatin / therapeutic use
  • Cetuximab / therapeutic use
  • Follow-Up Studies
  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • Induction Chemotherapy*
  • Paclitaxel / therapeutic use
  • Squamous Cell Carcinoma of Head and Neck / drug therapy

Substances

  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Carboplatin
  • Paclitaxel
  • Cetuximab